Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project.

ABSTRACT: BACKGROUND:Safe and effective use of pre-exposure prophylaxis (PrEP) depends on retention in care after initial engagement. SETTING:The United States PrEP Demonstration Project offered daily oral tenofovir/emtricitabine to participants in San Francisco, Miami, and Washington, D.C. for 48 weeks from 2012 to 2014. METHODS:The Demo Project participants' patterns of retention were assigned to 1 of 3 categories: early loss to follow-up (ELTF) within the first 12 weeks of the study, retention throughout the study, or intermittent retention in which missed or delayed visits resulted in gaps in medication availability. For each group, baseline characteristics were tabulated. A two-step multivariable analysis was performed. RESULTS:Overall, 366/554 (66.1%) of enrolled participants were retained for

SUBMITTER: Doblecki-Lewis S 

PROVIDER: S-EPMC6092210 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature